يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"INT2GRATE"', وقت الاستعلام: 1.33s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Advancing Precision Oncology in Hereditary Paraganglioma-Pheochromocytoma Syndromes: Integrated Interpretation and Data Sharing of the Germline and Tumor Genomes

    المؤلفون: Huma Q. Rana, Diane R. Koeller, McKenzie Walker, Busra Unal, Alison Schwartz Levine, Anu Chittenden, Raymond A. Isidro, Connor P. Hayes, Monica D. Manam, Ryan M. Buehler, Danielle K. Manning, Justine A. Barletta, Jason L. Hornick, Judy E. Garber, Arezou A. Ghazani, INT2GRATE Oncology Consortium

    المصدر: Cancers, Vol 16, Iss 5, p 947 (2024)

    مصطلحات موضوعية: INT2GRATE Oncology Consortium, somatic and germline integration, INT2GRATE, tumor signature profile, germline VUS, hereditary paraganglioma–pheochromocytoma syndromes (HPPGLs), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://www.mdpi.com/2072-6694/16/5/947; https://doaj.org/toc/2072-6694

    URL الوصول: https://doaj.org/article/9ac0d0ed287c4142a6b82ba22a827c2d

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Development and evaluation of INT2GRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndrome

    المؤلفون: Raymond A. Isidro, Anu Chittenden, McKenzie Walker, Alison Schwartz, Diane R. Koeller, Connor P. Hayes, Busra Unal, Monica Devi Manam, Ryan M. Buehler, Danielle K. Manning, Lynette M. Sholl, Mark S. Redston, Matthew B. Yurgelun, Huma Q. Rana, Judy E. Garber, Arezou A. Ghazani

    المصدر: Frontiers in Oncology, Vol 13 (2024)

    مصطلحات موضوعية: somatic and germline integration, INT2GRATE, tumor signature profile, germline VUS, Lynch syndrome, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://www.frontiersin.org/articles/10.3389/fonc.2023.1284690/full; https://doaj.org/toc/2234-943X

    URL الوصول: https://doaj.org/article/6d8a9b32038a4cdca4bc04f27dba67f4

    Full Text Finder
    أضف إلى المفضلة
  3. 3
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  4. 4
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Development and evaluation of INT 2 GRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndrome.

    المؤلفون: Isidro RA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Chittenden A; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States., Walker M; Division of Genetics, Brigham and Women's Hospital, Boston, MA, United States., Schwartz A; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States., Koeller DR; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States., Hayes CP; Division of Genetics, Brigham and Women's Hospital, Boston, MA, United States., Unal B; Division of Genetics, Brigham and Women's Hospital, Boston, MA, United States., Manam MD; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Buehler RM; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States., Manning DK; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Redston MS; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Yurgelun MB; Harvard Medical School, Boston, MA, United States.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, United States., Rana HQ; Harvard Medical School, Boston, MA, United States.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, United States., Garber JE; Harvard Medical School, Boston, MA, United States.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, United States., Ghazani AA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Division of Genetics, Brigham and Women's Hospital, Boston, MA, United States.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.

    المصدر: Frontiers in oncology [Front Oncol] 2024 Jan 24; Vol. 13, pp. 1284690. Date of Electronic Publication: 2024 Jan 24 (Print Publication: 2023).

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

    Full Text Finder
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء